LeadershipInvestigatorsCareersContact

Home / About / Leadership

Leadership

The people behind Kestrel

Kestrel's board of directors, management team, and scientific and venture advisors.

Governance

Board of Directors

Roy Richards Jr.Roy Richards Jr. Chair
Robert V. Farese Jr.Robert V. Farese Jr., MD Board MemberChief Executive Officer
Mike McCuneMike McCune, MD, PhD Board Member
Steve MillerSteve Miller, MD Board Member
Nancy Richards FareseNancy Richards Farese Board Member

Operations

Management

Robert V. Farese Jr.Robert V. Farese Jr., MD Chief Executive Officer
Laura Vasquez-Bolanos, PhD Director of Programs and Operations
Keri McCormickKeri McCormick Executive Administrator

Science

Scientific Advisory Board

Cagla Eroglu, PhD Duke University
C. Dirk Keene

C. Dirk Keene, MD, PhD

Florence Riford Alzheimer’s Disease Research Endowed ChairProfessor and Chair, Department of Pathology University of California San Diego

Dr. Keene is a Board-certified neuropathologist formerly at University of Washington where he founded and directed the UW BioRepository and Integrated Neuropathology (BRaIN) lab and the Pacific Northwest Brain Donor Network, which supported major research efforts to develop reference cell and circuit atlases of human brain in the BRAIN Initiative. In 2026, Dr. Keene moved to University of California San Diego to become Chair of the Department of Pathology and director of the Center for Neurodegeneration Science in support of the Allen Brain Health Accelerator and other prospective neurodegenerative disease studies. Dr. Keene is multiple PI of the Seattle Alzheimer’s Disease Brain Cell Atlas (SEA-AD), incoming Leader of the UCSD Shiley Marcos Alzheimer’s Disease Research Center Neuropathology Core, co-director of the Parkinson’s Precision Medicine Initiative (PPMI) Pathology core, and holder of the Florence Riford Alzheimer’s Disease Research endowed chair.

The primary goals for Dr. Keene’s research lab are to develop, deploy, and promote technologies that accentuate the scientific utility of archived and prospectively acquired human brain tissue, to utilize discoveries derived from these critical resources to develop and test hypotheses in experimental systems, and to apply this knowledge to develop therapeutic strategies.

Bruce MillerBruce Miller, MD University of California, San Francisco
William MobleyWilliam Mobley, MD, PhD University of California San Diego
Roy ParkerRoy Parker, PhD University of Colorado Boulder
Gia VoeltzGia Voeltz, PhD University of Colorado Boulder

Translation

Venture Advisory Board

Heather Clark, MS Chief Executive OfficerReCode Therapeutics
Ben Cravatt, PhD ProfessorScripps Research
Jeff Kelly, PhD ProfessorScripps Research
Paul Klingenstein Founder and Managing PartnerAberdare Ventures

Keep up with the latest

News on Kestrel research, investigators and events, a few times a year.